NASDAQ:AUGX • US05105P1075
Past quarterly earnings results for AUGMEDIX INC (AUGX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q2 2024 | -0.13 | -0.14 | 4.41% | -8.33% | 13.664M | 13.909M | -1.76% | 26.75% |
| Q1 2024 | -0.12 | -0.14 | 12.20% | 14.29% | 13.471M | 13.634M | -1.20% | 39.91% |
| Q4 2023 | -0.09 | -0.10 | 11.76% | 40.00% | 12.68M | 12.715M | -0.28% | 44.91% |
| Q3 2023 | -0.10 | -0.12 | 16.56% | 42.56% | 11.767M | 11.653M | 0.98% | 49.71% |
| Q2 2023 | -0.12 | -0.13 | 9.50% | 40.00% | 10.78M | 10.579M | 1.90% | 47.07% |
| Q1 2023 | -0.14 | -0.16 | 10.00% | 12.50% | 9.628M | 9.549M | 0.83% | 37.74% |
| Q4 2022 | -0.15 | -0.16 | 4.09% | - | 8.75M | 8.684M | 0.76% | 32.98% |
| Q3 2022 | -0.17 | - | 8.38% | 7.86M | 7.907M | -0.59% | 39.61% | |
| Q2 2022 | -0.20 | -0.16 | -26.50% | -17.65% | 7.33M | 7.481M | -2.02% | 41.78% |
| Q1 2022 | -0.16 | -0.16 | -2.86% | - | 6.99M | 7.041M | -0.72% | 45.93% |
| Q4 2021 | -0.15 | -0.16 | 4.97% | - | 6.58M | 6.525M | 0.84% | 44.93% |
| Q3 2021 | -0.19 | -0.11 | -77.40% | - | 5.63M | 5.734M | -1.81% | 32.47% |
| Q2 2021 | -0.17 | -0.19 | 12.28% | - | 5.17M | 5.282M | -2.12% | 38.61% |
| Q1 2021 | - | - | 4.79M | - | 20.65% | |||
| Q4 2020 | - | - | 4.54M | - | - | |||
| Q3 2020 | - | - | 4.25M | - | - | |||
| Q2 2020 | - | - | 3.73M | - | - | |||
| Q1 2020 | - | - | 3.97M | - | - |
Notes
AUGMEDIX INC (AUGX) last reported earnings on 8/12/2024.
AUGMEDIX INC (AUGX) beat EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, AUGMEDIX INC (AUGX) has beaten EPS estimates in 4 out of 4 releases.